pLX307-VHL(Y98H)-3F-BirA
(Plasmid
#220148)
-
PurposeExpresses VHL(Y98H)-BirA as a control for VHL substrate identification by E-STUB
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 220148 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLEX_307 (Plasmid #41392)
- Backbone size w/o insert (bp) 8400
- Total vector size (bp) 10099
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namevon Hippel-Lindau tumor suppressor
-
Alt nameVHL
-
SpeciesH. sapiens (human)
-
Mutationchanged tyrosine 98 to histidine; codon optimized
-
Entrez GeneVHL (a.k.a. HRCA1, RCA1, VHL1, pVHL)
- Promoter EF-1a
-
Tag
/ Fusion Protein
- 3F-BirA (C terminal on insert)
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer EF1a-F
- 3′ sequencing primer WPRE-R (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byThe Weissman Lab (pJW1512, Addgene Plasmid #62366)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLX307-VHL(Y98H)-3F-BirA was a gift from William Sellers (Addgene plasmid # 220148 ; http://n2t.net/addgene:220148 ; RRID:Addgene_220148) -
For your References section:
Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates. Huang HT, Lumpkin RJ, Tsai RW, Su S, Zhao X, Xiong Y, Chen J, Mageed N, Donovan KA, Fischer ES, Sellers WR. Nat Chem Biol. 2024 Mar 21. doi: 10.1038/s41589-024-01590-9. 10.1038/s41589-024-01590-9 PubMed 38514884